Our previous work has underscored the cyclooxygenase (COX)-2/prostaglandin E2 (PGE2) axis as a nodal protumourigenic inflammatory pathway often co-opted by cancer cells to drive immune evasion and resistance to ICB. This evidence concerns the gene PTGS2 and cancer.